250 related articles for article (PubMed ID: 6442563)
41. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
[TBL] [Abstract][Full Text] [Related]
42. [Paget disease of the skeleton. Internal medicine aspects].
Ziegler R; Baldauf G
Radiologe; 1984 Sep; 24(9):401-7. PubMed ID: 6238341
[TBL] [Abstract][Full Text] [Related]
43. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
[TBL] [Abstract][Full Text] [Related]
44. Diphosphonate therapy of paget's disease of bone.
Canfield R; Rosner W; Skinner J; McWhorter J; Resnick L; Feldman F; Kammerman S; Ryan K; Kunigonis M; Bohne W
J Clin Endocrinol Metab; 1977 Jan; 44(1):96-106. PubMed ID: 401827
[TBL] [Abstract][Full Text] [Related]
45. [Paget's disease: errors to be avoided].
Fournié A; Fournié B; Lassoued S
Rev Prat; 1989 Apr; 39(13):1143-6. PubMed ID: 2499920
[TBL] [Abstract][Full Text] [Related]
46. Synthetic human calcitonin in refractory Paget's disease of bone.
Altman RD; Collins-Yudiskas B
Arch Intern Med; 1987 Jul; 147(7):1305-8. PubMed ID: 3111398
[TBL] [Abstract][Full Text] [Related]
47. Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.
Adami S; Salvagno G; Guarrera G; Montesanti F; Garavelli S; Rosini S; Lo Cascio V
Calcif Tissue Int; 1986 Oct; 39(4):226-9. PubMed ID: 2947663
[TBL] [Abstract][Full Text] [Related]
48. [Therapy of Paget's disease of bone].
Ziegler R; Frank K
Dtsch Med Wochenschr; 1988 Jan; 113(3):102-5. PubMed ID: 3123193
[No Abstract] [Full Text] [Related]
49. Bone scintigraphy in Paget's disease treated with combined calcitonin and diphosphonate (EHDP).
Vellenga CJ; Pauwels EK; Bijvoet OL; Hosking DJ; Frijlink WB
Metab Bone Dis Relat Res; 1982; 4(2):103-11. PubMed ID: 6815413
[TBL] [Abstract][Full Text] [Related]
50. [Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
Sieghart S
Wien Med Wochenschr; 1986 Nov; 136(21-22):583-5. PubMed ID: 3103338
[TBL] [Abstract][Full Text] [Related]
51. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.
Khairi MR; Altman RD; DeRosa GP; Zimmermann J; Schenk RK; Johnston CC
Ann Intern Med; 1977 Dec; 87(6):656-63. PubMed ID: 412450
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of drugs for Paget's disease of bone.
Reginster JY; Lecart MP
Bone; 1995 Nov; 17(5 Suppl):485S-488S. PubMed ID: 8573423
[TBL] [Abstract][Full Text] [Related]
53. [Therapy of Paget's disease of bone with diphosphonates and calcitonin].
Ziegler R; Holz G; Minne H; Delling G
Verh Dtsch Ges Inn Med; 1978; (84):1122-5. PubMed ID: 741902
[No Abstract] [Full Text] [Related]
54. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
[No Abstract] [Full Text] [Related]
55. Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone.
Meunier PJ; Chapuy MC; Alexandre C; Bressot C; Edouard C; Vignon C; Mathieu L; Trechsel U
Lancet; 1979 Sep; 2(8141):489-92. PubMed ID: 90215
[TBL] [Abstract][Full Text] [Related]
56. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
Roux C; Gennari C; Farrerons J; Devogelaer JP; Mulder H; Kruse HP; Picot C; Titeux L; Reginster JY; Dougados M
Arthritis Rheum; 1995 Jun; 38(6):851-8. PubMed ID: 7779130
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
Stein I; Shapiro B; Ostrum B; Beller ML
Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
[TBL] [Abstract][Full Text] [Related]
58. Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).
Frijlink WB; Bijvoet OL; te Velde J; Heynen G
Lancet; 1979 Apr; 1(8120):799-803. PubMed ID: 86042
[TBL] [Abstract][Full Text] [Related]
59. Treatment of Paget's disease of bone.
Singer FR
Postgrad Med; 1975 Mar; 57(3):117-20. PubMed ID: 123333
[No Abstract] [Full Text] [Related]
60. [Calcitonin nasal spray for Paget's disease of the bone].
Luboshitzky R; Bar-Shalom R
Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
